R&D TeaM


Kathleen Molnar, Ph.D.

Kathleen joined ViewPoint as a scientist in October of 2016.  She received a PhD in biochemistry and biophysics from the University of Pennsylvania in 2015, and a BSE in chemical engineering from Princeton University in 2004.  Between degrees, she worked at ExSAR Inc. and collaborated with pharma companies, providing hydrogen-deuterium exchange mass spectrometry experiments and data analysis. Continuing her interest in protein structure and function, her thesis in Bill DeGrado's lab centered on structural changes involved in signaling in bacterial two-component systems. Kathleen has expertise in protein biochemistry, mass spectrometry, molecular biology, and biophysical methods.


Bryan DUnYak, Ph.D.

Bryan joined ViewPoint Therapeutics as a Research Scientist in July of 2017. He received his Ph.D. in biological chemistry from the University of Michigan in 2016, and a B.S. in Chemistry from Michigan State University in 2011. Bryan’s graduate work involved the design of bifunctional molecules that permit cell-specific targeting. During his postdoctoral work at University of California - San Francisco, he worked on projects focused on drug discovery for cancer and neurodegeneration. Bryan has expertise in a multidisciplinary set of skills ranging from organic chemistry, biochemistry, biophysics, and cell biology.


Bonnie Su

Bonnie joined ViewPoint in 2017 as a research associate. She received her undergraduate degree in Molecular and Cell Biology from UC Berkeley in 2017. Bonnie studied the genetics of cataracts in mice as an undergraduate researcher and was awarded the Spencer W. Brown Award in Genetics, Genomics and Development for excellence in genetics research from UC Berkeley.